Attempts were made to relabel stolen product with counterfeit labels, says NJ Star-Ledger
Although the trial is yet to be held, a fuller story of the Enfield, CT burglary—with product worth $75-80-million, making it the arguably the largest burglary of any kind in US history—has been published by the NJ Star-Ledger newspaper. Nearly two dozen individuals were arrested, and the ringleaders remain in jail. Some of the same defendants were involved in a 2009 burglary of a GSK warehouse in Chesterfield, VA, with the same modus operandi—cutting through a roof, neutralizing the alarms, and then loading up some $4.3-million worth of Advair Diskus respiratory drugs. DNA left on coffee cups, water bottles and other items linked one of the defendants to both burglaries as well as others.
FBI agents were able to trace newly purchases tools left at the Enfield robbery to a Home Depot in Flushing, NY, and also to tie one of the defendants to air travel and a car rental in that area at that time. A later clue, according to FBI affidavit details in the newspaper story, came up when a parcel sent from the Dominican Republic, to a marina frequented by the defendants, was intercepted by US Customs in Florida. FBI investigators believe that the labels were meant to be used on the stolen Lilly products—which might indicate that the burglary ring was aware of the importance of pedigree documentation and matching label information. Ultimately, little or none of the stolen Lilly product showed up in retail outlets, although apparently some of the stolen Advair product had.
By late 2010, FBI and police agencies in Florida and New Jersey were picking up hints from informants that drug-fencing transactions were being scheduled, some of which were surveilled and recorded. FBI moved on May 3 to arrest a total of 22 men.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.